Skip to main content
NVAX logo

NVAX · Novavax Inc · Executive Compensation

Track NVAX — free
$7.91 -0.06 (-0.69%) Play latest call Q2 2026 earnings call transcript
Market Cap
$1.31B
Shares
165.01M
Volume · Nov 19 1.15M Avg daily vol (3M) 6.86M

Named-executive compensation from the company's DEF 14A proxy statements — salary, bonus, stock and option awards, non-equity incentive, and the company-reported total per executive per fiscal year, exactly as disclosed in the Summary Compensation Table.

Fiscal 2025
Executive Total
John C. Jacobs $8,856,015
Elaine O'Hara $3,688,276
James P. Kelly $2,986,228
Mark J. Casey $2,810,453
Ruxandra Draghia-Akli $2,303,380
John J. Trizzino $1,709,950
Fiscal 2024
Executive Total
John C. Jacobs $5,087,461
James P. Kelly $1,829,489
Elaine O'Hara $1,638,116
John J. Trizzino $1,633,417
Filip Dubovsky $1,554,368
Mark J. Casey $1,062,334
Fiscal 2023
Executive Total
John C. Jacobs $7,269,509
Stanley C. Erck $3,827,483
Filip Dubovsky $1,934,392
John J. Trizzino $1,877,883
Mark J. Casey $1,534,587
James P. Kelly $1,503,833
Fiscal 2022
Executive Total
Stanley C. Erck $8,401,283
Gregory Glenn $4,093,686
James P. Kelly $3,181,336
John A. Herrmann III $3,095,314
John J. Trizzino $3,078,230
Fiscal 2021
Executive Total
James P. Kelly $4,925,939
Stanley C. Erck $1,118,030
John J. Trizzino $1,064,179
Gregory Glenn $813,444
John A. Herrmann III $657,802
Fiscal 2020
Executive Total
Stanley C. Erck $48,086,018
Gregory Glenn $24,923,376
John J. Trizzino $21,327,954
John A. Herrmann III $20,606,814
Gregory F. Covino $1,417,774
Fiscal 2019
Executive Total
Stanley C. Erck $2,438,562
Gregory Glenn $1,875,198
John J. Trizzino $1,465,602
John A. Herrmann III $1,353,416
Gregory F. Covino —
Gregory Covino —
Fiscal 2018
Executive Total
Stanley C. Erck $4,158,398
Gregory Glenn $1,681,456
John J. Trizzino $1,329,776
John A. Herrmann III $1,137,576
Gregory Covino —
Gregory F. Covino —
Fiscal 2017
Executive Total
Stanley C. Erck $2,771,685
Gregory Glenn $1,221,250
John J. Trizzino $947,747
John A. Herrmann III $913,317

Executive changes

Person Change Filed
John Trizzino Terminated 2025-05-27
Charles W. Newton Appointed 2025-04-29
John W. Shiver Appointed 2025-03-11
James F. Young
“Dr. Young’s resignation from the Board is not the result of any disagreement with the Company on any matter relating to the Company’s operations, policies or practices.”
Resigned 2025-03-11
Margaret G. McGlynn Appointed 2024-06-14
David Mott Appointed 2024-06-14
Richard H. Douglas, Ph.D. Appointed 2024-06-14
Filip Dubovsky Retired 2024-05-23
Mark Casey Appointed 2023-11-17
John A. Herrmann III Retired 2023-11-17
John J. Trizzino Appointed 2023-11-17
Richard J. Rodgers Appointed 2023-07-11
Gregg H. Alton, J.D. Appointed 2023-07-11
John C. Jacobs Appointed 2023-07-11
Dr. Gregory M. Glenn, M.D. Retired 2023-03-22
Dr. Gregory M. Glenn, M.D. Retired 2023-03-02
Stanley C. Erck Retired 2023-01-09
John C. Jacobs Appointed 2023-01-09
Stanley C. Erck Retired 2023-01-09
John C. Jacobs Appointed 2023-01-09
Richard J. Rodgers Appointed 2022-11-01
James F. Young, Ph.D. Appointed 2022-06-21
Rachel K. King Appointed 2022-06-21
Rajiv I. Modi, Ph.D. Resigned 2022-03-07

Leadership

Key facts CIK 1000694 CUSIP 670002401 13F (30d) 290 filings 249 filers Visit website Investor relations